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Supplementary Materials and Methods
Assay Development
In order to optimize our existing validated screening assay (20) to increase throughput and capacity we made a number of adaptations. We conducted pilot experiments using a small selection of BioFocus compound plates with the aim of scaling up the procedure. Having previously determined that three replicates were needed for assay robustness (20), we focused on logistical considerations that would improve throughput. For the primary screen we replaced the CellTiter-Glo® readout for cell toxicity with a microscopy scoring system and changed the reagent mastermix used in the qPCR analysis from QuantiTect SYBR® Green (Qiagen) to SsoFast™ EvaGreen® (BioRad), to reduce the qPCR run time.
The former change reduced the number of plates requiring set up by 50% while the latter reduced the qPCR run time by more than 50%. Finally, the workflow was streamlined by increasing resources in terms of personnel, equipment and software to prevent bottlenecks in DNA extraction, qPCR, data analysis and hit determination. All of these amendments to the published protocol were validated using analysis of Z and Z′ statistical parameters and the subsequent primary screening of the library was completed in less than 1 year.
Primary Screening Workflow
Stock compound plates contained 54 compounds per plate. Daughter plates were prepared to avoid multiple freeze-thawing of stocks. Dilution plates were prepared from these on day 0 and added in triplicate to cell plates containing 10,000 cells per well. One plate of compounds resulted in three cell plates, each containing 18 compounds in triplicate as well as vehicle (dimethyl sulfoxide, DMSO) and doxycycline controls in triplicate. A typical run contained a batch of four compound plates (216 compounds) resulting in 12 cell plates. Plates were incubated for nine days at 26 °C and then scored for cytotoxicity using microscopy (medium toxicity determined as approximately 50% or greater reduction in cell confluence in comparison to the DMSO control, high toxicity approximately 90% or greater reduction in confluence). DNA plates were prepared from cell lysates using a 96-well DNA extraction protocol, resulting in eight plates from a typical run. qPCR targeting the 16S rRNA gene of Wolbachia was conducted using a 384-well format and the quality of the resulting data was checked per cell plate using Z′ statistical analysis. Data from plates that did not meet a Z′ threshold of 0.4 were discarded and compounds were set up again in the next run of assay set up. For those that passed this analysis (>90% of plates), Wolbachia 16S log reductions ('log drop') were calculated per compound using in plate DMSO controls and those that achieved a 1 log drop or above were considered hits, thus moving into confirmation screening.
Chemoinformatic Analysis
High potency, as assessed by the measured log drop, was considered ideal, while compounds which displayed <70% in the CellTiter-Glo® assay were considered toxic and given a low priority. All of the 50 hit compounds possessed purity >90%. All chemotypes were also assessed for their ability to act as either covalent binders, promiscuous compounds, toxicophores or give false positive results in compound screens (58-64). Covalent binders, such as alkylating and acylating agents, may be chemically reactive towards proteins and are also be prone to hydrolysis (exhibiting poor stability in serum) leading to unpredictable toxicity. The validated hit compounds were also examined for structures that have been identified as promiscuous ("frequent hitters"). Such molecules that generate hits in many different assays covering a wide range of targets are therefore not specific enough to be suitable drug candidates as they are more likely to exhibit off-target toxic effects. The hits were also assessed for the presence of toxicophores as these represent features or groups within a chemical structure that may be responsible for compounds toxic properties, either directly, or through metabolic activation. None of the In order to focus on chemotypes that would minimize the chance of off-target effects all the hit compounds were assessed computationally for their likelihood of showing high affinity for P450 enzyme (2C9), P-glycoprotein transporter (P-gp), human Ether-a-go-go-Related Gene (hERG) channel and CNS penetration (55). These endpoints were chosen as inhibition of P450 can lead to toxic drugdrug-interactions (65), P-gp is an efflux transporter on the surface of gastrointestinal cells that can oppose the absorption of molecules (66) and if a compound binds to the hERG K + channel then cardiotoxicity issues can present themselves (67). These ADME predictions did not present any outstanding major issues with any of the hits.
Calculation of Selection Score
Compounds which showed a log drop of greater than 1 unit scored 15, those with a log drop between 0.5 and 1 were assigned 10 and those compounds with a log drop <0.5 score 5. An important property was the lipophilicity of the compound, consequently compounds with calculated logP less than 4 scored 6, those with logP between 4 and 6 scored 3 whilst those with ClogP greater than 6 scored only one point.
Another important consideration was the number of compounds in each cluster as we wished to highlight those compound series which contain numerous molecules. When a cluster contained more than 10 compounds each compound scored 6; where a cluster contained between 5 and 10 compounds each compound scored 3, whilst compounds within clusters with less than 5 compounds only scored 1 point. The rationale for this approach being that evidence of initial SAR is indicative of a series amenable to lead optimization. Compounds were also assigned points by their molecular weight with those less than 400 scored 3 points, between 400 and 600 2 points and above 600 were assigned 1 point.
Pareto Optimization
All properties (calculated and measured physicochemical, ADME) were used in a Pareto selection procedure to identify the best hit series. In this case we have used Pareto optimization to identify the series which are most potent, least toxic with best physiochemical and ADMET profiles (35, 68) . Upon performing the Pareto optimization compounds from each of the six chemotypes were ranked equally highly, giving us confidence in the quality of all the clusters for further optimization.
Synthesis of AWB124
Preparation of 2-chloro-N-(2-(trifluoromethyl)benzyl)thieno [3,2-d] in 1,4-dioxane (5 ml), isopropylamine (0.60 g, 0.87 ml, 10 mmol, 10 eq.) was heated to 120 o C in sealtube for 48 hours. After that, 1,4-dioxane and the excess isopropylamine was removed under vacuum. 
